An investigation into the current peri-operative nutritional management of oesophageal carcinoma patients in major carcinoma centres in England

By Murphy PM   Modi P   Rahamim J   Wheatley T   Lewis SJ  

Annals of The Royal College of Surgeons of England, Vol. 88, Iss. 4, 2006-07 ,pp. : 358-362

The Royal College of Surgeons of England

Access to resources Recommend Favorite

Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatment

By Taneja S.S.   Pierce W.   Figlin R.   Belldegrun A.  

Urology, Vol. 45, Iss. 6, 1995-06 ,pp. : 911-924

Elsevier

Access to resources Recommend Favorite

Serum Levels of Soluble Interleukin-2 Receptor in Renal Cell Carcinoma

By Matsumoto T.   Furukawa A.   Sumiyoshi Y.   Akiyama K.-y.   Kanayama H.-o.   Kagawa S.  

Urology, Vol. 51, Iss. 1, 1998-01 ,pp. : 145-149

Elsevier

Access to resources Recommend Favorite

Survival analysis in patients with pulmonary metastatic renal cell carcinoma (MRCC) treated by inhaled interleukin-2 (IL-2) compared to prognostic stratification models

By Heinzer H.   Toma M.   Huland E.   Huland H.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 99-99

Elsevier

Access to resources Recommend Favorite

A survey of the peri-operative management of urological patients on clopidogrel

By Mukerji Gaurav   Munasinghe Indumina   Raza Asif  

Annals of The Royal College of Surgeons of England, Vol. 91, Iss. 4, 2009-05 ,pp. : 313-320

The Royal College of Surgeons of England

Access to resources Recommend Favorite